4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001692444-26-000003
Director sold 27,594 shares at $78.05 ($2,153,712)
- Director acquired 27,594 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Soteropoulos Paula Director | 2026-03-24 | Option exercise 10b5-1 | +27,594 | $8.44 | $232,893 | 27,594 | D |
| Soteropoulos Paula Director | 2026-03-24 | Sale 10b5-1 | −27,594 | $78.05 | $2,153,712 | 0 | D |
| Derivatives | |||||||
| Soteropoulos Paula Director | 2026-03-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,594 | 1,198 | D | ||
| Open-market sales · 27,594 sh · avg $78.05 · $2,153,712 | |||||||
Loading xslF345X06/ownership.xml…